Regencell Bioscience Holdings Limited

Healthcare · Drug Manufacturers - Specialty & Generic · Hong Kong

Last price 6.71 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.33B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.